| Bile acid physiology A Di Ciaula, G Garruti, RL Baccetto, E Molina-Molina, L Bonfrate, ... Annals of hepatology 16 (1), 4-14, 2018 | 438 | 2018 |
| Nonalcoholic fatty liver disease M Krawczyk, L Bonfrate, P Portincasa Best practice & research Clinical gastroenterology 24 (5), 695-708, 2010 | 277 | 2010 |
| Gut microbiota and short chain fatty acids: implications in glucose homeostasis P Portincasa, L Bonfrate, M Vacca, M De Angelis, I Farella, E Lanza, ... International journal of molecular sciences 23 (3), 1105, 2022 | 274 | 2022 |
| Biochemical mechanisms in drug-induced liver injury: certainties and doubts I Grattagliano, L Bonfrate, CV Diogo, HH Wang, DQH Wang, P Portincasa World journal of gastroenterology: WJG 15 (39), 4865, 2009 | 246 | 2009 |
| Obesity and the risk and prognosis of gallstone disease and pancreatitis L Bonfrate, DQH Wang, G Garruti, P Portincasa Best practice & research Clinical gastroenterology 28 (4), 623-635, 2014 | 177 | 2014 |
| Therapy of gallstone disease: What it was, what it is, what it will be P Portincasa, A Di Ciaula, L Bonfrate, DQH Wang World journal of gastrointestinal pharmacology and therapeutics 3 (2), 7, 2012 | 172 | 2012 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 163 | 2022 |
| Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal … P Vitellio, G Celano, L Bonfrate, M Gobbetti, P Portincasa, M De Angelis Nutrients 11 (4), 886, 2019 | 123 | 2019 |
| Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options L Bonfrate, J Tack, I Grattagliano, R Cuomo, P Portincasa Scandinavian journal of gastroenterology 48 (9), 995-1009, 2013 | 118 | 2013 |
| Liver steatosis, gut-liver axis, microbiome and environmental factors. A never-ending bidirectional cross-talk A Di Ciaula, J Baj, G Garruti, G Celano, M De Angelis, HH Wang, ... Journal of clinical medicine 9 (8), 2648, 2020 | 116 | 2020 |
| Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. P Portincasa, L Bonfrate, ML Scribano, A Kohn, N Caporaso, D Festi, ... Journal of Gastrointestinal & Liver Diseases 25 (2), 2016 | 116 | 2016 |
| Mitochondria in chronic liver disease I Grattagliano, S Russmann, C Diogo, L Bonfrate, P J Oliveira, ... Current drug targets 12 (6), 879-893, 2011 | 116 | 2011 |
| Targets for current pharmacologic therapy in cholesterol gallstone disease A Di Ciaula, DQH Wang, HH Wang, L Bonfrate, P Portincasa Gastroenterology Clinics 39 (2), 245-264, 2010 | 109 | 2010 |
| Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study A Zullo, G Scaccianoce, V De Francesco, V Ruggiero, P D’Ambrosio, ... Clinics and research in hepatology and gastroenterology 37 (6), 647-650, 2013 | 105 | 2013 |
| Management of liver cirrhosis between primary care and specialists I Grattagliano, E Ubaldi, L Bonfrate, P Portincasa World journal of gastroenterology: WJG 17 (18), 2273, 2011 | 101 | 2011 |
| The food-gut human axis: the effects of diet on gut microbiota and metabolome M De Angelis, G Garruti, F Minervini, L Bonfrate, P Portincasa, M Gobbetti Current Medicinal Chemistry 26 (19), 3567-3583, 2019 | 98 | 2019 |
| Intestinal barrier and permeability in health, obesity and NAFLD P Portincasa, L Bonfrate, M Khalil, MD Angelis, FM Calabrese, M D’amato, ... Biomedicines 10 (1), 83, 2021 | 94 | 2021 |
| Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients L Bonfrate, DM Di Palo, G Celano, A Albert, P Vitellio, M De Angelis, ... European Journal of Clinical Investigation 50 (3), e13201, 2020 | 92 | 2020 |
| Sourdough fermented breads are more digestible than those started with baker’s yeast alone: an in vivo challenge dissecting distinct gastrointestinal responses CG Rizzello, P Portincasa, M Montemurro, DM Di Palo, MP Lorusso, ... Nutrients 11 (12), 2954, 2019 | 87 | 2019 |
| Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies? A Di Ciaula, S Passarella, H Shanmugam, M Noviello, L Bonfrate, ... International Journal of Molecular Sciences 22 (10), 5375, 2021 | 84 | 2021 |
